The Finnish Medicines Agency (Fimea) compiles, produces, evaluates and distributes evidence-based impartial information on pharmaceuticals to the general. biological preparatory medicine that improves immunity to a particular disease. Research Groups. Fundamental and translational research in the Department of Ophthalmology is conducted by two research groups located in Canthia.
|Published (Last):||5 November 2004|
|PDF File Size:||2.67 Mb|
|ePub File Size:||3.10 Mb|
|Price:||Free* [*Free Regsitration Required]|
New Employee at the UEF
Automatic implantable cardioverter defibrillators in Chagas heart disease patients with malignant ventricular arrhythmias.
Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagas’ic myocarditis: Later evolution after cardiac transplantation in Chagas’ disease. Cardiac thrombosis and thromboembolism in chronic Chagas’ heart disease. Assessment of heart neurons in dilated congestive cardiomyopathy. Rev Soc Bras Med Trop. An estimate of the burden of Chagas disease in the United States.
Stroke in a hospital-derived cohort of patients with chronic Chagas’ disease. The prognostic value of the electrocardiographic features of chronic Chagas’ disease.
Detection of early right ventricular dysfunction in Chagas disease using Doppler tissue imaging. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: Continuando nessa linha de pensamento, Costa e cols. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas’ cardiomyopathy. A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy.
Myocardial parasite persistence in chronic chagas’ic patients. Chagas disease American Trypanosomiasisits impact on transfusion and clinical medicine. J Thorac Cardiovasc Surg. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: Control of Chagas Disease.
Risk progression to chronic Chagas cardiomyopathy: Aldosterone antagonism in an inflammatory state: A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
Chagas’ heart disease and the autonomic nervous system. Ann Trop Med Parasitol.
Cohn JN, Tognoni G. A retrospective search for maternal transmission of Chagas infection from patients in the chronic phase. Potencial Conflito de Interesses. Ensinando e aprendendo um novo estilo de cuidar.
Ventricular arrhythmia in Chagas disease: Autoimmunity against the second extracellular loop of b1-adrenergic receptors induces early afterdepolarization and decreases in K-channel density in rabbits.
Conclusiones y recomendaciones generales. J Am Coll Cardiol. Mechanisms of pathogenesis in Chagas disease. Chagas disease in bone marrow tranplantation. Morphometric and histological analysis of the superior cervical ganglion in experimental Chagas’ disease in rats. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: How cardoopatia cite this article.
Research groups | UEF
Carvedilol Heart Failure Study Group. Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas’ heart disease.
Kluwer Academic Publishers; Finalmente, o ECO de estresse pode induzir arritmias ventriculares complexas mesmo em pacientes em fases precoces da cardiopatia Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas’ heart disease. Lifetime risk for developing congestive heart failure: Sao Paulo Med J. Sergio Salles Xavier Participantes: Chagas’ disease reactivation after heart transplantation: Cardiac morbity due to Chagas heart disease.
La Iniciativa del Cono Sur.